These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 11799636)
1. The case for lipid control. Lipold AG Bus Health; 2001 Dec; 19(12 Suppl A):12-5. PubMed ID: 11799636 [No Abstract] [Full Text] [Related]
2. Measure for measure--sugar or fats? Reconciling cardiovascular and diabetes risk with niacin therapy. Rosenson RS Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):72-3. PubMed ID: 17237831 [No Abstract] [Full Text] [Related]
3. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction. Sacks FM Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082 [No Abstract] [Full Text] [Related]
4. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus. Steiner G Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087 [TBL] [Abstract][Full Text] [Related]
5. Do we need a fasting lipid profile to assess cardiovascular risk? Grunberger G J Diabetes; 2011 Sep; 3(3):172-3. PubMed ID: 21668658 [No Abstract] [Full Text] [Related]
6. The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk. Sulkes D; Brown BG; Krauss RM; Segrest JP; Sniderman AD; Roberts WC Am J Cardiol; 2008 Mar; 101(6):828-42. PubMed ID: 18328849 [No Abstract] [Full Text] [Related]
7. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves. Sherman FT Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951 [No Abstract] [Full Text] [Related]
8. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. Jones PH Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089 [TBL] [Abstract][Full Text] [Related]
10. New insights into understanding cardiometabolic risk. Introduction. Fonarow GC; Watson KE Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389 [No Abstract] [Full Text] [Related]
11. Use it or lose it: exercise, diabetes and CVD. Gottlieb SH Diabetes Forecast; 2002 May; 55(5):39-41. PubMed ID: 14964157 [No Abstract] [Full Text] [Related]
12. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus. Gotto AM Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053 [TBL] [Abstract][Full Text] [Related]
13. Treating diabetes: cardiovascular benefits of antidiabetes drugs. Harmel AP Am J Manag Care; 2002 May; 8(8 Suppl):S219-28; quiz S229-32. PubMed ID: 12022237 [TBL] [Abstract][Full Text] [Related]
14. Lipid screening and cardiovascular health in childhood. Daniels SR; Greer FR; Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007 [TBL] [Abstract][Full Text] [Related]
15. Moderate exercise reduces the risk of heart disease and death in men with type 2 diabetes. Rollins G Rep Med Guidel Outcomes Res; 2003 Jun; 14(11):10, 12. PubMed ID: 12877117 [No Abstract] [Full Text] [Related]
16. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum. Karasik A Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol goals established for patients with diabetes and metabolic syndrome. Haffner SM Am J Manag Care; 2002 Jan; Suppl():6-7. PubMed ID: 11833456 [No Abstract] [Full Text] [Related]
18. "K-ration". Diabetes and cardiovascular risk. Gottlieb SH Diabetes Forecast; 2002 Feb; 55(2):44-6. PubMed ID: 14959668 [No Abstract] [Full Text] [Related]
19. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Daousi C; Casson IF; Gill GV; MacFarlane IA; Wilding JP; Pinkney JH Postgrad Med J; 2006 Apr; 82(966):280-4. PubMed ID: 16597817 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Ahmed I; Goldstein BJ Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]